BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loi M, Desideri I, Greto D, Mangoni M, Sottili M, Meattini I, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Bonomo P, Livi L. Radiotherapy in the age of cancer immunology: Current concepts and future developments. Crit Rev Oncol Hematol 2017;112:1-10. [PMID: 28325250 DOI: 10.1016/j.critrevonc.2017.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Sun Z, Liu X, Song J, Liu H, Zhang S, Luo J. Immune infiltration could predict the efficacy of short-term radiotherapy in patients with cervical cancer. Clin Transl Oncol 2022. [PMID: 36510039 DOI: 10.1007/s12094-022-03033-0] [Reference Citation Analysis]
2 Meattini I, Livi L, Lorito N, Becherini C, Bacci M, Visani L, Fozza A, Belgioia L, Loi M, Mangoni M, Lambertini M, Morandi A. Integrating radiation therapy with targeted treatments for breast cancer: from bench to bedside. Cancer Treatment Reviews 2022. [DOI: 10.1016/j.ctrv.2022.102417] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kumar D, Thakar S, Bansode DA, Rai GK. Prospects and Challenges in the Treatment of Solid Tumors. Environmental Chemistry for a Sustainable World 2022. [DOI: 10.1007/978-3-031-14848-4_18] [Reference Citation Analysis]
4 Fiorentino A, Gregucci F, Desideri I, Fiore M, Marino L, Errico A, Di Rito A, Borghetti P, Franco P, Greto D, Donato V. Radiation treatment for adult rare cancers: Oldest and newest indication. Crit Rev Oncol Hematol 2021;159:103228. [PMID: 33508447 DOI: 10.1016/j.critrevonc.2021.103228] [Reference Citation Analysis]
5 Zhang Md J, Zhang Md L, Yang Md Y, Liu Md Q, Ma Md H, Huang Md A, Zhao Md Y, Xia Md Z, Liu Md T, Wu Md G. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells. Int J Radiat Oncol Biol Phys 2021;109:1533-46. [PMID: 33238192 DOI: 10.1016/j.ijrobp.2020.11.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li X, Li S, Pang J, Huang F, Guo B, Liu H. [Alkaline processing of cantharidin can significanty improve the antitumor activity of cantharidin]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1332-9. [PMID: 32990225 DOI: 10.12122/j.issn.1673-4254.2020.09.17] [Reference Citation Analysis]
7 Patel RR, Verma V, Barsoumian HB, Ning MS, Chun SG, Tang C, Chang JY, Lee PP, Gandhi S, Balter P, Dunn JD, Chen D, Puebla-Osorio N, Cortez MA, Welsh JW. Use of Multi-Site Radiation Therapy for Systemic Disease Control. Int J Radiat Oncol Biol Phys 2021;109:352-64. [PMID: 32798606 DOI: 10.1016/j.ijrobp.2020.08.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
8 Cun-Jin S, Jian-Hao X, Xu L, Feng-Lun Z, Jie P, Ai-Ming S, Duan-Min H, Yun-Li Y, Tong L, Yu-Song Z. X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activation. Mol Pain 2019;15:1744806919849201. [PMID: 31012378 DOI: 10.1177/1744806919849201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liang H, Shen X. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells. Biochem Biophys Res Commun 2020;528:330-5. [PMID: 32448508 DOI: 10.1016/j.bbrc.2020.04.137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
10 Cecchin E, De Mattia E, Dreussi E, Montico M, Palazzari E, Navarria F, Bergamo F, Belluco C, Quartuccio L, De Vita S, Canzonieri V, Gagno S, Zanusso C, Buonadonna A, Pucciarelli S, De Paoli A, Toffoli G. Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiother Oncol 2020;149:30-7. [PMID: 32387487 DOI: 10.1016/j.radonc.2020.04.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Bonomo P, Lucidi S, Desideri I, Scotti V, Casati M, Palomba A, Ciabatti C, Garlatti P, Massi D, Gallo O, Livi L. Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report. Clin Transl Radiat Oncol 2020;23:16-9. [PMID: 32368625 DOI: 10.1016/j.ctro.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Ellerin BE, Demandante CGN, Martins JT. Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches. Cancer Radiother 2020;24:226-46. [PMID: 32192840 DOI: 10.1016/j.canrad.2020.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Loi M, Nuyttens JJ, Desideri I, Greto D, Livi L. Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives. Cancer Manag Res 2019;11:9397-408. [PMID: 31807069 DOI: 10.2147/CMAR.S186630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Patente TA, Pinho MP, Oliveira AA, Evangelista GCM, Bergami-Santos PC, Barbuto JAM. Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Front Immunol 2018;9:3176. [PMID: 30719026 DOI: 10.3389/fimmu.2018.03176] [Cited by in Crossref: 130] [Cited by in F6Publishing: 145] [Article Influence: 32.5] [Reference Citation Analysis]
15 Hughes VS, Wiggins JM, Siemann DW. Tumor oxygenation and cancer therapy-then and now. Br J Radiol 2019;92:20170955. [PMID: 29513032 DOI: 10.1259/bjr.20170955] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
16 Rückert M, Deloch L, Fietkau R, Frey B, Hecht M, Gaipl US. Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies. Strahlenther Onkol 2018;194:509-19. [PMID: 29500551 DOI: 10.1007/s00066-018-1287-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
17 Ceresoli GL, Gianoncelli L, Bonomi M, Cerchiaro E, Bombardieri E. Novel Approaches of Treatment with Radium-223 Targeted Therapy. Clinical Applications of Nuclear Medicine Targeted Therapy 2018. [DOI: 10.1007/978-3-319-63067-0_28] [Reference Citation Analysis]
18 Rückert M, Deloch L, Fietkau R, Frey B, Gaipl US. Interaktionen von Strahlen- und Immuntherapie. Onkologe 2017;23:823-830. [DOI: 10.1007/s00761-017-0267-x] [Reference Citation Analysis]